Posluma Injection
Product Images NDC 69932-002

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Posluma (NDC 69932-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blue Earth Diagnostics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pos04 0007 01)

Chemical structure of flotufolastat F-18, the active ingredient in POSLUMA injection. The diagram shows the molecular arrangement including the gallium ion complex, fluorine-18 isotope, and associated organic ligands as part of the compound's structure.*

FDA Label Image

Blue Earth Diagnostics Logo (Pos04 0007 02)

FDA Label Image

Posluma Final Printed Carton And Container Label (Pos04 0009 03)

Drug information panel for Posluma (flotufolastat F 18) Injection, a non-pyrogenic, intravenous radiopharmaceutical with 158 mCi/mL strength. The panel includes dosing activity details, storage instructions (20°C to 25°C), and caution about radioactivity. It is a multiple-dose vial from Blue Earth Diagnostics, with warnings about discoloration and particulate matter and mentions a 10-hour usage window after end of synthesis (EOS).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.